My Partner, Tom Tobin, who runs our healthcare business, will have a note out on this later on. Bottom line is that this is a positive incremental event for Allergan. Bottom line is that this is a positive incremental event for the company. My short term upside target is $57.83. We are long it in the Hedgeye Portfolio.
- KM
chart courtesy of stockcharts.com
